Analysts have slightly lowered their price target for Borregaard from NOK 217.50 to NOK 214.75. This change is due to minor adjustments in discount rate and valuation metrics after reviewing updated forecasts.
What's in the News
- The Norwegian Research Council has awarded NOK 15 million to support Borregaard’s Biomer innovation initiative, focused on developing bio-based alternatives to traditional fossil-based polymers in agriculture, industry, and household products (Regulatory Authority / Compliance).
- Borregaard experienced an unforeseen outage at its Sarpsborg facility, resulting in restricted production of speciality cellulose and delays in certain shipments, while production of other biorefinery products remained unaffected (Halt/Resume of Operations / Unusual Events).
- Borregaard ASA recently held an Analyst/Investor Day, offering updates and insights to stakeholders (Analyst/Investor Day).
Valuation Changes
- Consensus Analyst Price Target has decreased slightly from NOK 217.50 to NOK 214.75.
- The discount rate has increased marginally, rising from 6.78% to 6.83%.
- The revenue growth forecast has edged up from 5.74% to 5.79%.
- The net profit margin estimate has increased from 14.80% to 17.39%.
- The future P/E ratio expectation has fallen from 19.28x to 16.52x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.